HealthBaby - Macau
AboutParent bank: HealthBaby
HealthBaby Biotech (Macau) Co., Ltd. is part of HealthBaby Group, the most established Asian cord blood bank with branches across Hong Kong, Macau, Thailand, Taiwan (HealthBanks) and USA (PacifiCord) with over 15 years experience. Apart from the global network, HealthBaby Group also attained various international accreditations. Our Taiwan branch (HealthBanks) is the FIRST Asian cord blood bank accredited by Foundation for Accreditation of Cellular Therapy (FACT). HealthBaby Macau relies on the processing and storage facility in Hong Kong, which is the MOST1 accredited cord blood laboratory in Hong Kong (including CAP, AABB and HOKLAS). HealthBaby offers comprehensive umbilical cord blood and umbilical cord tissue storage service. HealthBaby offers umbilical cord tissue storage service, and has exclusively attained H.K., U.S., Taiwan and China Patented technology for extracting the whole cord tissue as well as unique processing, storage and culture technologies that enhance the quantity and viability of tissue cells after thawing.
HealthBaby Group was established and dedicated to cord blood industry since 2001. The HealthBaby Group is the only Asian cord blood bank which is capable of setting up a branch in the United States and successfully passed FDA (Food and Drug Administration) rigorous and unexpected inspection in January 2010 and April 2011. The Group has cryopreserved over 120,000 cord blood units (December 2016).
HealthBaby works beyond the cord blood and umbilical cord stem cells storage services, we devote abundant resources in biotechnology research projects exploring stem cells medical applications for the betterment of human health.
Apart from stem cell banking services, HealthBaby Group owns additional businesses in the biotechnology sector, including:
- GMP grade pharmaceutical company – Purzer Pharmaceutical Co., Ltd,
- Animal vaccines development company – Reber Genetics Co., Ltd
- Human vaccines development company – TheVax Genetics Vaccine.
At present, HealthBaby Group becomes an international leading biotechnology company with strong financial integrity to provide life-long and reliable service to clients.
1. IMS 2010 Cord Blood Bank Market Research in Hong Kong (with Private O&G physicians)
2. Ipsos Healthcare 2009-2016 Cord Blood Bank Survey
HealthBaby provides specialized cord blood and cord collection kits with necessary collection tools (e.g. JMS blood bags, syringe and vacutainers etc) and detailed guidelines to OB/GYN doctors. The collection kits will be passed to enrolled clients in advance.
HealthBaby's container is thermal-insulated to provide stable storage conditions. A data logger is used to monitor the temperature throughout the transportation process to ensure the cord blood sample maintains a constant temperature.
HealthBaby provides in-house free-of-charge cord blood and cord samples collection service from designated hospitals (Hong Kong and Macau region) upon notification.
HealthBaby adopts a specialized, FDA-cleared stem cells processing system: AXP® AutoXpress® Platform. AXP® consistently retrieves 98.7% MonoNuclear Cells (MNC) and 96.2% Total Nucleated Cells (TNC), based on audit by US Obstetrics & Gynaecology Society, which is about 18% higher than other systems. Samples are sterilized and processed individually to avoid mix-up.
HealthBaby is the ONLY private cord blood bank in Hong Kong that adopts the state-of-the-art and FDA-cleared automatic stem cells storage system: BioArchive® System. BioArchive® adopted closed system and automatic retrieval operation to eliminate the great temperature difference occurred in traditional storage tanks. Liquid nitrogen (-196℃) storage medium provides stable temperature and maintains the highest cell viability. BioArchive® is adopted by 127 cord blood banks in 36 countries worldwide, including Hong Kong public cord blood bank.
Licensing & Accreditation
Apart from AABB accreditation, HealthBaby is the FIRST and cord blood laboratory in Hong Kong accredited with the College of American Pathologists (CAP) and Hong Kong Laboratory Accreditation Scheme (HOKLAS), which prove the techniques, quality and storage service met up with the stringent standard of authoritative organizations.
HealthBaby Group has released over 1,000 cord blood units for HLA matching worldwide. Over 41 transplant cases including Unrelated/Direct Allogenic and Autologous, have been performed by over 20 medical institutions worldwide. HealthBaby has also released the most cord blood units for autologous cord blood transplants in Hong Kong: 2 pediatrics patients with Cerebral Palsy and 1 with Neuroblastoma have successfully received their cord blood, currently with satisfactory recovery.
HealthBaby offers full refund and compensation policies to protect clients's interests covering aspects of cord blood delivery, man-made negligence or accidents. HealthBaby is also the first cord blood bank committing a full refund and worldwide cord blood replacement or compensation up to US$50,000, as well as HK$20 million Professional Indemnity Insurance providing the greatest protection for clients. Besides, stem cells viability report is announced annually to ensure sample quality.
Please call HealthBaby hotline at 852 3188 8899 to know more about our service plan. Interest-free installment payment is available upon request.
HLA Typing Service is available as optional service.